IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,497,648 | +52.5% | 155,519 | +68.5% | 0.00% | – |
| Q2 2023 | $981,775 | -66.6% | 92,272 | -67.0% | 0.00% | -100.0% |
| Q1 2023 | $2,937,426 | +61.5% | 279,223 | +90.2% | 0.00% | – |
| Q4 2022 | $1,819,199 | -37.5% | 146,828 | -47.7% | 0.00% | -100.0% |
| Q3 2022 | $2,909,000 | +692.6% | 280,748 | +780.9% | 0.00% | – |
| Q2 2022 | $367,000 | -93.8% | 31,871 | -93.3% | 0.00% | -100.0% |
| Q1 2022 | $5,952,000 | -63.6% | 473,147 | -66.3% | 0.00% | – |
| Q4 2021 | $16,352,000 | +85.2% | 1,402,390 | +107.4% | 0.00% | -100.0% |
| Q3 2021 | $8,830,000 | +7.0% | 676,034 | +5.4% | 0.00% | 0.0% |
| Q2 2021 | $8,255,000 | +19.4% | 641,402 | +3.7% | 0.00% | – |
| Q1 2021 | $6,913,000 | -72.8% | 618,299 | -72.3% | 0.00% | -100.0% |
| Q4 2020 | $25,396,000 | +191.3% | 2,229,680 | +130.0% | 0.00% | +100.0% |
| Q3 2020 | $8,719,000 | -4.4% | 969,388 | +9.6% | 0.00% | -50.0% |
| Q2 2020 | $9,124,000 | +16.1% | 884,114 | +13.5% | 0.00% | 0.0% |
| Q1 2020 | $7,861,000 | -10.8% | 779,135 | +17.7% | 0.00% | 0.0% |
| Q4 2019 | $8,810,000 | +20.5% | 661,878 | -22.3% | 0.00% | 0.0% |
| Q3 2019 | $7,311,000 | -70.1% | 851,683 | -61.8% | 0.00% | -33.3% |
| Q2 2019 | $24,422,000 | +332.9% | 2,232,292 | +435.3% | 0.00% | +50.0% |
| Q1 2019 | $5,642,000 | +41.2% | 417,000 | +8.1% | 0.00% | +100.0% |
| Q4 2018 | $3,997,000 | -33.4% | 385,800 | +18.7% | 0.00% | 0.0% |
| Q3 2018 | $6,002,000 | -36.8% | 325,146 | -34.5% | 0.00% | -66.7% |
| Q2 2018 | $9,491,000 | +559.1% | 496,376 | +432.0% | 0.00% | – |
| Q1 2018 | $1,440,000 | +103.1% | 93,300 | +97.3% | 0.00% | – |
| Q4 2017 | $709,000 | -85.3% | 47,283 | -84.5% | 0.00% | -100.0% |
| Q3 2017 | $4,821,000 | +143.6% | 305,700 | +191.7% | 0.00% | +100.0% |
| Q2 2017 | $1,979,000 | -15.4% | 104,800 | -23.6% | 0.00% | 0.0% |
| Q1 2017 | $2,339,000 | -41.5% | 137,100 | -47.6% | 0.00% | -50.0% |
| Q4 2016 | $4,001,000 | +101.3% | 261,639 | +109.0% | 0.00% | +100.0% |
| Q3 2016 | $1,988,000 | +11.5% | 125,200 | -8.2% | 0.00% | 0.0% |
| Q2 2016 | $1,783,000 | -11.2% | 136,400 | -25.7% | 0.00% | 0.0% |
| Q1 2016 | $2,008,000 | -26.6% | 183,629 | -22.2% | 0.00% | 0.0% |
| Q4 2015 | $2,734,000 | -43.9% | 235,883 | -49.6% | 0.00% | -50.0% |
| Q3 2015 | $4,874,000 | -28.1% | 467,802 | -16.7% | 0.00% | 0.0% |
| Q2 2015 | $6,775,000 | -37.4% | 561,745 | -17.0% | 0.00% | -60.0% |
| Q1 2015 | $10,829,000 | +258.1% | 676,836 | +242.8% | 0.01% | +400.0% |
| Q4 2014 | $3,024,000 | -47.6% | 197,430 | -55.7% | 0.00% | -66.7% |
| Q3 2014 | $5,772,000 | +58.7% | 445,538 | +87.8% | 0.00% | +200.0% |
| Q2 2014 | $3,637,000 | +4.2% | 237,269 | -16.3% | 0.00% | 0.0% |
| Q1 2014 | $3,492,000 | -46.4% | 283,356 | -49.5% | 0.00% | -75.0% |
| Q4 2013 | $6,519,000 | +104.3% | 561,544 | +108.5% | 0.00% | +100.0% |
| Q3 2013 | $3,191,000 | +123.5% | 269,287 | +87.5% | 0.00% | +100.0% |
| Q2 2013 | $1,428,000 | – | 143,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |